Journal of the International Association of Physicians in AIDS Care · 2010 · 15 citations · 21 references
MedicineNephrologyBone MetabolismCalcium HomeostasisRenal PathophysiologyBone DisordersBone HealthBone Metabolism DisordersBone PathologyMetabolic Bone DiseasePhosphate HomeostasisBone Health DisordersBone Health Supportive TherapyBone Mineral DensityBone Mineral Density DeclineBone Pain PalliationChronic Disease - Related Bone LossDrug Effects On Bone DensityPhosphorus Metabolism
Two adult patients living with AIDS presented with severe bone pain associated with tenofovir (TDF) use. Both were unable to walk without assistance and were severely restricted in their movement due to the bone pain. Both had mild renal impairment, Fanconi syndrome, and bone mineral density (BMD) loss. Bone pain and inability to walk were reversible with the cessation of TDF and supplementation with Vitamin D(3), calcium, and phosphate. These cases appear to be examples of the severity of BMD loss associated with TDF use and suggest not only attention to renal function with TDF use, but also monitoring of alkaline phosphatase (bone fraction) and plasma phosphorus as indicators of BMD loss.
21
Clemens Bergwitz, Nicole M. Roslin, Martin Tieder et al. · The American Journal of Human Genetics · 2006 · 488 citations · Full text
Bettina Lorenz‐Depiereux, Anna Benet‐Pagès, Gertrud Eckstein et al. · The American Journal of Human Genetics · 2006 · 373 citations · Full text
Tenofovir‐associated renal and bone toxicity
IG Williams, Sara Madge, Andrew Copas et al. · HIV Medicine · 2009 · 300 citations · Full text